Kestra Private Wealth Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.45M | Buy |
8,984
+260
| +3% | +$41.9K | 0.02% | 598 |
|
2025
Q1 | $1.48M | Buy |
8,724
+268
| +3% | +$45.6K | 0.02% | 544 |
|
2024
Q4 | $1.41M | Sell |
8,456
-388
| -4% | -$64.5K | 0.02% | 532 |
|
2024
Q3 | $1.52M | Sell |
8,844
-640
| -7% | -$110K | 0.03% | 492 |
|
2024
Q2 | $1.46M | Buy |
9,484
+100
| +1% | +$15.4K | 0.03% | 470 |
|
2024
Q1 | $1.44M | Sell |
9,384
-391
| -4% | -$60.1K | 0.03% | 461 |
|
2023
Q4 | $1.54M | Sell |
9,775
-611
| -6% | -$96.6K | 0.04% | 422 |
|
2023
Q3 | $1.52M | Buy |
10,386
+254
| +3% | +$37.2K | 0.05% | 367 |
|
2023
Q2 | $1.55M | Buy |
10,132
+191
| +2% | +$29.3K | 0.05% | 347 |
|
2023
Q1 | $1.54M | Buy |
9,941
+30
| +0.3% | +$4.65K | 0.06% | 317 |
|
2022
Q4 | $1.53M | Sell |
9,911
-55
| -0.6% | -$8.48K | 0.08% | 283 |
|
2022
Q3 | $1.32M | Buy |
9,966
+137
| +1% | +$18.1K | 0.08% | 286 |
|
2022
Q2 | $1.33M | Sell |
9,829
-394
| -4% | -$53.4K | 0.08% | 292 |
|
2022
Q1 | $1.53M | Sell |
10,223
-4,659
| -31% | -$695K | 0.08% | 274 |
|
2021
Q4 | $2.41M | Sell |
14,882
-252
| -2% | -$40.8K | 0.12% | 186 |
|
2021
Q3 | $2.51M | Sell |
15,134
-205
| -1% | -$34K | 0.14% | 164 |
|
2021
Q2 | $2.65M | Sell |
15,339
-3,624
| -19% | -$626K | 0.16% | 143 |
|
2021
Q1 | $3.04M | Buy |
18,963
+870
| +5% | +$140K | 0.21% | 114 |
|
2020
Q4 | $3.06M | Sell |
18,093
-875
| -5% | -$148K | 0.23% | 110 |
|
2020
Q3 | $2.96M | Buy |
+18,968
| New | +$2.96M | 0.26% | 94 |
|